Northern Technologies Reports Sharp Decline in Net Income and EPS, Cuts Dividend by 85%
summarizeSummary
Northern Technologies International Corp. reported a significant decline in net income and diluted EPS for Q1 FY2026, alongside an 85% reduction in its cash dividend, despite a 9.2% increase in consolidated net sales.
check_boxKey Events
-
Net Income and EPS Decline
Net income attributable to NTIC decreased 57.6% to $237,819, and diluted EPS fell 50% to $0.03 for the quarter ended November 30, 2025, compared to the prior year.
-
Dividend Cut
The Board of Directors declared a cash dividend of $0.01 per share, an 85% reduction from the $0.07 per share declared in the prior year.
-
Operating Cash Flow Plunges
Net cash provided by operating activities decreased significantly by 85.7% to $341,908 for the quarter.
-
Sales Growth Amidst Profitability Challenges
Consolidated net sales increased 9.2% to $23.3 million, driven by ZERUST oil & gas sales, but higher cost of goods sold and operating expenses impacted overall profitability.
auto_awesomeAnalysis
The company's first-quarter results show a concerning trend with net income attributable to NTIC dropping by 57.6% and diluted EPS by 50% year-over-year. This financial deterioration is further underscored by an 85.7% decrease in net cash provided by operating activities. The Board's decision to drastically cut the quarterly dividend from $0.07 to $0.01 per share signals significant financial pressure. While consolidated net sales increased by 9.2%, driven by strong ZERUST oil & gas demand and a new $13.1 million contract, the higher cost of goods sold and increased operating expenses, partly due to strategic investments and tariffs, eroded profitability. Investors should monitor the impact of tariffs on the Natur-Tec segment and the realization of revenue from the new ZERUST contract against the backdrop of declining cash flow and reduced shareholder returns.
At the time of this filing, NTIC was trading at $9.00 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $82.9M. The 52-week trading range was $6.75 to $13.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.